# Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee

> **NCT01221441** · PHASE2 · COMPLETED · sponsor: **Kolon TissueGene, Inc.** · enrollment: 102 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **BIOLOGICAL:** TissueGene-C
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT01221441
- **Lead sponsor:** Kolon TissueGene, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-10
- **Final completion:** 2014-10
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2016-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01221441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01221441, "Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01221441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*